<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04872855</url>
  </required_header>
  <id_info>
    <org_study_id>CSP2017-10</org_study_id>
    <nct_id>NCT04872855</nct_id>
  </id_info>
  <brief_title>Observational Study to Evaluate Clinical Performance and Safety in Total Knee Arthroplasty</brief_title>
  <official_title>Observational Study to Evaluate the Performance and the Safety of the HLS KneeTec Cementless or Hybrid Fixations in Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corin</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the long-term performance and safety of HLS KneeTec&#xD;
      cementless and hybrid fixation knee prosthesis when used in standard medical practice.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is planned to collect prospective and retrospective data from a continuous and exhaustive&#xD;
      series of patients in French sites where Total Knee Arthroplasty with HLS Kneetec cementless&#xD;
      and hybrid fixation knee prosthesis is performed routinely&#xD;
&#xD;
      All patients treated with HLS KneeTec (cementless or hybrid versions) implant will be&#xD;
      included. All eligible patients seen in consultation and who agree to participate in the&#xD;
      study should be included, systematically and consecutively, since the initiation of the&#xD;
      study.&#xD;
&#xD;
      Patients will be assessed according to the usual practice of the investigator at each&#xD;
      participating site before surgery and then at the follow-up (FU) visits as following: 4&#xD;
      months (+/- 2 months); 1 year (+/- 2 months); 5 years (+/- 12 months) and 10 years (+/- 12&#xD;
      months).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 17, 2020</start_date>
  <completion_date type="Anticipated">January 15, 2032</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2031</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of implant survival in subjects receiving a total knee arthroplasty with the HLS KneeTec cementless and hybrid fixations up to 10 years after the surgery</measure>
    <time_frame>10-year</time_frame>
    <description>Kaplan Meier survival rate up to 10 years after the surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of clinical performance of the HLS KneeTec cementless and hybrid fixations after the surgery</measure>
    <time_frame>starting preoperatively up to 10 years</time_frame>
    <description>IKS score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of clinical performance of the HLS KneeTec cementless and hybrid fixations after the surgery</measure>
    <time_frame>5 and 10 years</time_frame>
    <description>Oxford Knee Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic analysis of the HLS KneeTec cementless and hybrid fixations at 4 months, 1, 5 and 10 years minimum</measure>
    <time_frame>4 months, 1, 5 and 10 years</time_frame>
    <description>radiological analysis from immediate postoperative up to 10-year FU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of safety performance during the surgery up to 10 years after the surgery</measure>
    <time_frame>starting intraoperatively up to 10-year FU</time_frame>
    <description>Number, severity and casual relationship of procedure or implant-related adverse events</description>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Total Knee Arthroplasty</condition>
  <condition>Knee Disease</condition>
  <condition>Total Knee Replacement</condition>
  <condition>Osteo Arthritis Knee</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>patient with knee arthroplasty</intervention_name>
    <description>patient with HLS KneeTec cementless and hybrid fixation prosthesis</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients treated with HLS KneeTec (cementless or hybrid versions) implant will be&#xD;
        included. All eligible patients seen in consultation and who agree to participate in the&#xD;
        study should be included, systematically and consecutively, since the initiation of the&#xD;
        study&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female aged 18 - 80 years old at the time of the surgery&#xD;
&#xD;
          -  Implanted (or with an indication) with an HLS KneeTec Cementless or hybrid fixation&#xD;
             according to the Instructions for Use (IFU)&#xD;
&#xD;
          -  Patients agree to consent to collect data from their medical records and agree to&#xD;
             answer questionnaires for the purposes of the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Patients under guardianship and/or those who, according to the investigator or his&#xD;
        delegated research team, will not be able to comply with the study procedures. (e.g.&#xD;
        illiteracy, recent psychotic or manic disorders and/or inability to comply with routine&#xD;
        follow-up visits.)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Franck MABESOONE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH COMPIEGNE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vanessa GRIMAUD</last_name>
    <phone>0667267075</phone>
    <email>vanessa.grimaud@coringroup.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chu Angers</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Florian DUCELLIER, MD</last_name>
      <email>flducellier@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Florian DUCELLIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Du Parc</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertrand GALAUD, MD</last_name>
      <phone>+33231828282</phone>
      <email>bertrandgalaud@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Bertrand GALAUD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Compiegne Noyon</name>
      <address>
        <city>Compiègne</city>
        <zip>60200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franck MABESOONE, MD</last_name>
      <email>F.MABESOONE@ch-compiegnenoyon.fr</email>
    </contact>
    <investigator>
      <last_name>Max-Olivier ROUX, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cécile LATERZA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Franck MABESOONE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 26, 2021</study_first_submitted>
  <study_first_submitted_qc>April 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2021</study_first_posted>
  <last_update_submitted>May 17, 2021</last_update_submitted>
  <last_update_submitted_qc>May 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Knee Arthroplasty</keyword>
  <keyword>Prosthesis</keyword>
  <keyword>Implants</keyword>
  <keyword>HLS implants</keyword>
  <keyword>arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

